A clinical trial by ClubStargate for a pill named Ease was suspended because it contained methylone, which was claimed by the Ministry of Health to fall under New Zealand controlled drug analogue laws (although this was never proven in court). Piperazines have been described as ‘failed pharmaceuticals’, as some had been evaluated as potential therapeutic agents by pharmaceutical companies but never brought to the market 1. One piperazine that has been commonly used as NPS is 1-benzylpiperazine (BZP) though other piperazine derivatives have also been reported.
- Therefore, we determined the most frequently occurring NPS in The Netherlands and combined this with data regarding drug-related intoxications.
- There are two positional isomers of mCPP, namely 1-(4-chlorophenyl)piperazine (also known as pCPP, para-CPP, 4CPP and 4Cl-PP) and 1-(2-chlorophenyl piperazine, (also known as oCPP, ortho-CPP, 2CPP and 2Cl-PP).
- Factors such as age, gender, race, environment, and drug treatment may have considerable influence on the activity of these enzymes.
- TFMPP is controlled in Texas under Penalty Group 2, as a hallucinogenic substance.
- Piperazines are a very broad chemical group, covering a wide range of drugs from antidepressants to antihistamines.
Update On 1-benzylpiperazine (BZP) Party Pills
Dose–effect curves were generated for MDMA, BZP, and TFMPP by testing 8–10 concentrations of each drug in assays. Substrate reversal experiments were performed to verify that monoamine transporter sites were involved in the releasing properties of drugs. Specifically, GBR12909 (10 nM) was used to antagonize DAT-mediated 3HMPP+ release, whereas fluoxetine (10 nM) was used to antagonize SERT-mediated 3H5-HT release.
Types Of Drugs
- Anderton’s idea for a “D” rating, which would include party pills, has received considerable support.
- BZP + TFMPP – these two substances seem to work synergistically in the central nervous system.
- Consequently, there are significant differences between substituted piperazines and MDMA with respect to motor activity, and this may be attributable to direct postsynaptic actions of piperazine compounds.
- For CYP1A-mediated pathways, all the commonly used experimental models are appropriate except probably the dog.
It can be manufactured by reacting piperazine monohydrochloride with benzyl chloride. The latter precursor is readily available, and piperazine monohydrochloride is easily produced from the commercially-available salts. It is known that 1,4-dibenzylpiperazine (DBZP) can be formed as a side-product in this reaction. Piperazine derivatives are usually found in illicit dosage forms as either tablets or capsules, but loose powders also occur.
1 LC-MS Method—MRM Transitions And Chromatographic Separation
Though some researchers have indicated club drug users are more likely to be polydrug users, there remains little known about the prevalence and specific combinations of the substances they use. Between 2004 and 2006, and using time-space sampling, a stratified sample of 400, year-old New York City club-going, drug-using young adults were recruited into the Club Drugs and Health Project. Most participants (91.7%) had engaged in polydrug usage and 1,670 combinations of drugs were reported. Ecstasy (86.6% of users) and cocaine (85.7% of users) were the two most-frequently reported club drugs used in combination with other substances. Other frequently cited 849 drug combinations included cocaine and marijuana, ecstasy and marijuana, LSD and marijuana, and cocaine and alcohol.
Addictive Effects
Piperazine derivatives belong to the basic chemical structures for the preparation of new compounds acting on the serotoninergic system 9. Many studies have described the structure-activity relationship of large numbers of compounds with a chemical structure to the arylpiperazine side chain 9,51. The attempts are still being made to develop metabolically stable derivatives as drug candidates 52. Mixing piperazines with alcohol can be particularly dangerous – the effects of these two substances interact, and you may also be less in control, making use much riskier 2.
The Risks
It seems surprising that BZP produces elevations in dialysate 5-HT in vivo, since the drug was inactive when tested as a releaser of 3H5-HT in vitro. However, we have noted inconsistencies between in vitro and in vivo effects of monoamine releasers in prior studies. Methamphetamine, for example, displays nearly 30-fold greater potency as a releaser of 3HDA vs 3H5-HT in synaptosomes (Rothman et al, 2001), yet low i.v.
Designer Drugs: Mechanism Of Action And Adverse Effects
The resulting values ranged from 6.13 to 15.85 µM, which places studied derivatives as moderate or weak inhibitors of CYP3A4. BZP and TFMPP are amphetamine-like recreational drugs and the major active components of ‘party pills’. The pharmacodynamic effects of these neurally active drugs are thought to be dependent on their activity at DA and 5-HT receptors and several studies report drug-drug interactions at a pharmacodynamic level. Their metabolism involves the hepatic P450 enzymes CYP2D6, CYP1A2 and CYP3A4 resulting in inhibited metabolism of other drugs and medicines, as well as compromised metabolism in poor metabolisers for CYP2D6.
As of 2005, use among humans was limited to the treatment of parasitic worm infections. (1973), ‘A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests’, European journal of clinical pharmacology, Volume 6, No 3, pp. 163–169. Transporter-mediated release assays were carried out as previously described with minor modifications (Rothman et al, 2001). Tissue from caudate (for DAT assay), or from whole brain minus cerebellum and caudate (for SERT assay), was homogenized in ice-cold 10% sucrose containing 1 μM reserpine. For DAT-mediated release assays, 3H1-methyl-4-phenylpyridinium (3HMPP+) was used as the radiolabeled substrate; 100 nM desipramine and 100 nM citalopram were added to prevent uptake of 3HMPP+ into NE and 5-HT nerves.
Loss of control or inappropriate behavior may cause other people to view the user with suspicion. Addiction can lead the user to abandon educational goals and engage in criminal activity. Since the early 1950s, piperazines have been used widely by veterinarians as an anthelmintic drug. In humans, piperazine citrate serves a similar function and is used to treat pinworm and roundworm infestations in adults and children.
It is well established from preclinical findings that TFMPP is a non-selective 5-HT receptor agonist, with the drug exhibiting modest binding affinity (∼100 nM) for 5-HT1 and 5-HT2 receptor subtypes (Fuller, 1988; Hoyer, 1988). Similar to MDMA, however, TFMPP displays presynaptic actions that include stimulation of SERT-mediated 5-HT release from neurons, as demonstrated in vitro (Pettibone and Williams, 1984) and in vivo (Auerbach et al, 1991). There is limited information available on the molecular mechanism of BZP, but this drug elicits amphetamine-like behavioral effects in rodents (Jones et al, 1980) and humans (Bye et al, 1973).
The focus here will be on the recreationally used derivatives, that is the benzylpiperazines (i.e. BZP) and the methylenedioxy derivatives (e.g. TFMPP, mCPP, MeOPP), the latter being most similar to MDMA as its name suggests. A new ‘family” of drugs, the piperazines, has emerged on the European drug market as new designer drugs for the last few years. Piperazines are capable of disrupting a person’s ability to think, communicate, and act sensibly. As with other mind-altering substances, use of BZP or TFMPP may jeopardize work or school performance, ruin relationships, and increase the likelihood of involvements in accidents.
For SERT-mediated release assays, 3H5-HT was used as the radiolabeled substrate; 100 nM nomifensine and 100 nM GBR12935 were added to the sucrose solution to prevent uptake of 3H5-HT into NE and DA nerve terminals. Synaptosomal preparations were incubated to steady state with 5 nM 3HMPP+ (60 min) or 5 nM 3H5-HT (60 min) in Krebs-phosphate buffer (pH 7.4), plus 1 μM reserpine. Subsequently, 850 μl of synaptosomes preloaded with 3Hligand were added to polystyrene test tubes that contained 150 μl of test drug in assay buffer plus 1 mg/ml BSA. After 5 min (3H5-HT) or 30 min (3HMPP+) the release reaction was terminated by dilution with 4 ml wash buffer followed by rapid vacuum filtration. The retained tritium was counted by a Topcount liquid scintillation counter (Perkin-Elmer, Downers Grove, IL).
What Is BZP?
Elements of the measurement systems and operating parameters are presented in Table 9. New Psychoactive Substances (NPS) were listed as Class A controlled drugs in the First Schedule of the Misuse of Drugs Act on 1 May 2014. Consumption of Kratom can produce psychoactive or mind-altering effects. 1 First time etomidate e-vaporiser abusers will be given mandatory rehabilitation under the Tobacco (Control of Advertisements and Sale) Act. Piperazines are Class C drugs which means that they’re illegal to have for yourself, give away or sell.
Is It Dangerous To Mix With Other Drugs?
Basic pharmacokinetic properties are described for both BZP and TFMPP when taken alone and in combination. Several studies have shown that these drugs cause several drug-drug interactions. 1-Benzylpiperazine (BZP; see Molecular structure 1) is one of a small group of benzyl-substituted piperazines, but a much larger group comprises the phenylpiperazines (see Tables 1 and 2). Despite claims by some tablet and capsule suppliers that they are herbal products, piperazine and its derivatives are synthetic substances that do not occur naturally.
At the high dose of BZP/TFMPP (10 mg/kg, i.v.), extracellular DA was elevated to a greater extent than the summed effects of BZP and TFMPP alone, suggesting a synergistic effect on DA transmission when the drugs are combined (see Table 1). In contrast, the rise in extracellular 5-HT produced by BZP/TFMPP was similar to the additive effects of BZP plus TFMPP. Several rats receiving the high-dose combination developed seizures and subsequent ataxia. Although the seizures produced by BZP/TFMPP were short-lived and rats recovered completely, we did not investigate this phenomenon further due to animal welfare concerns. When BZP and TFMPP were incubated together during in vitro release assays, BZP did not alter ability of TFMPP to release 3H5-HT, and TFMPP did not alter the ability of BZP to release 3HMPP+ (data not shown). Thus, it appears that interactions of BZP and TFMPP with monoamine transporters cannot explain synergistic effects of the combination, and any number of mechanisms may underlie the apparent drug–drug synergism.
